Document is current

Any future updates will be listed below

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Crossref DOI link: https://doi.org/10.1186/s12885-016-2642-1

Published Online: 2016-08-18

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark